Document ID: chunk:federal_register_of_legislation:F2024C00988:reg:45:p3
Version: federal_register_of_legislation:F2024C00988
Segment Type: reg
Provision Reference: reg 45 (pt 3/3)
Character Range: 81514–84142

a particular medication chart prescription for the pharmaceutical benefit only if:
 (a) the prescription indicates either of the following:
 (i) that an ongoing supply of the pharmaceutical benefit is authorised for the period of validity of the chart;
 (ii) a stop date for the supply of the pharmaceutical benefit and, based on the dose and frequency of administration of the pharmaceutical benefit indicated in the prescription, more than one supply of a maximum quantity of the pharmaceutical item or pharmaceutical benefit is needed before the stop date is reached; and
 (b) the prescription is not for the supply of a pharmaceutical benefit referred to in Schedule 8 to the current Poisons Standard (within the meaning of the Therapeutic Goods Act 1989) to a person receiving treatment in or at a residential care service.
 (6) If paragraphs (5)(a) and (b) do not apply, an approved supplier may only supply the quantity of the pharmaceutical benefit needed to give effect to the prescription, up to a maximum quantity of the pharmaceutical item or pharmaceutical benefit.
Note: The following information entered in the prescription may also indicate the quantity of the pharmaceutical benefit that is needed:
(a) the dose and frequency of administration of the pharmaceutical benefit;
(b) the date of prescribing, or the start date (if any) for administration of the pharmaceutical benefit;
(c) the stop date (if any) for administration of the pharmaceutical benefit.
 (7) However, for a supply:
 (a) on the basis of a prescription referred to in subparagraph (5)(a)(i); or
 (b) referred to in subsection (6);
an approved supplier may supply up to a maximum quantity of the pharmaceutical item or pharmaceutical benefit even if the period of validity of the medication chart will end before administration of that quantity in accordance with the prescription would finish.

Matters in relation to electronic medication charts
 (8) For the purposes of subparagraph (2)(aa)(i), the electronic medication chart seen by the approved supplier:
 (a) must include the information mentioned in subparagraph 41(2)(a)(iii) (about dose, frequency of administration and route of administration) that is written in the chart in respect of the person for whom the pharmaceutical benefit is prescribed; but
 (b) does not need to include other information in the electronic medication chart about the administration of the pharmaceutical benefit to the person.

Information requirements for copies of electronic medication charts
 (9) The Secretary may, in writing, specify information requirements for the purposes of paragraph (2A)(a).